FDA Approves Lifesaving Medicine for Infantile-Onset NPC
The FDA approved Lembaz injection, the first treatment demonstrated to help patients with infantile-onset Niemann-Pick disease type C live longer.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed